- 全部删除
 
您的购物车当前为空
CZS-241 是一种口服有效的选择性 Polo-like Kinase (PLK)4抑制剂 (IC50=2.6 nM)。CZS-241 还抑制 TRKA,IC50值为 2.74 μM。CZS-241 诱导细胞凋亡 (apoptosis),阻滞细胞周期在 S/G2 期。CZS-241 对白血病细胞系表现出高效的抗增殖活性,对正常细胞系表现出安全性。

CZS-241 是一种口服有效的选择性 Polo-like Kinase (PLK)4抑制剂 (IC50=2.6 nM)。CZS-241 还抑制 TRKA,IC50值为 2.74 μM。CZS-241 诱导细胞凋亡 (apoptosis),阻滞细胞周期在 S/G2 期。CZS-241 对白血病细胞系表现出高效的抗增殖活性,对正常细胞系表现出安全性。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 25 mg | ¥ 10,600  | 6-8周 | |
| 50 mg | ¥ 13,800  | 6-8周 | |
| 100 mg | ¥ 17,500  | 6-8周 | 
CZS-241 相关产品
| 产品描述 | CZS-241 is an orally active, selective Polo-like Kinase (PLK) 4 inhibitor with an IC 50 of 2.6 nM that also inhibits TRKA at an IC 50 of 2.74 μM. It induces apoptosis and causes cell cycle arrest at the S/G2 phase, demonstrating potent antiproliferative effectiveness against leukemia cell lines while maintaining safety towards normal cell lines.  | 
| 靶点活性 |  TrkA:2.74 μM, PLK4:2.6 nM  | 
| 分子量 | 551.98 | 
| 分子式 | C26H24ClF2N9O | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容